Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties.

Grzegorz Framski; Dariusz Wawrzyniak; Zofia Jahnz-Wechmann; Agnieszka Szymanska-Michalak; Adam Kraszewski; Jan Barciszewski; Jerzy Boryski; Jacek Stawinski

doi:10.18388/abp.2016_1338

Grzegorz Framski
Dariusz Wawrzyniak
Zofia Jahnz-Wechmann
Agnieszka Szymanska-Michalak
Adam Kraszewski
Jan Barciszewski
Jerzy Boryski
Jacek Stawinski Institute of Bioorganic Chemistry Polish Academy Of Science, Poznan, Poland

DOI: https://doi.org/10.18388/abp.2016_1338

Keywords: Ribonucleoside analogues, anti-glioblastoma activity, anticancer ribonucleotides

Abstract

Several ribonucleoside analogues with modifications in the nucleobase and sugar moiety have been screened for anti-glioma activity in T98G glioma cell line using cervical (HeLa) as a reference human malignant cell, and lung fibroblast (MCR-5) as a non-cancerous reference cells. Among the investigated compounds, ribonucleosides containing 6-chloropurine (3), 7-guanine (5) and a pyrrolopyrimidine (18) as nucleobases, show promising anti-glioma activity with good selectivity indices, and can be considered as lead structures for further anti-cancer studies.

References

Agnihotri S, Burrell KE, Wolf A, Jalali S, Hawkins C, Rutka JT, Zadeh G (2013) Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp 61: 25-41.

Badisa RB, Darling-Reed SF, Joseph P, Cooperwood JS, Latinwo LM, Goodman CB (2009) Selective Cytotoxic Activities of Two Novel Synthetic Drugs on Human Breast Carcinoma MCF-7 Cells. Anticancer Research 29: 2993-2996.

Baraldi PG, Tabrizi MA, Gessi S, Borea PA (2008) Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility. Chem Rev 108: 238-263.

Benzaria S, Bardiot D, Bouisset T, Counor C, Rabeson C, Pierra C, Storer R, Loi AG, Cadeddu A, Mura M, Musiu C, Liuzzi M, Loddo R, Bergelson S, Bichko V, Bridges E, Cretton-Scott E, Mao J, Sommadossi J-P, Seifer M, Standring D, Tausek M, Gosselin G, La Colla P (2007) 2′-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication. Antiviral Chem Chemother 18: 225-242.

Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108: 11-27.

Boryski J (1995) Transglycosylation of β-D-Ribofuranosylindazoles. Nucleosides and Nucleotides 14: 77-89.

Boryski J (1998) A Novel Approach to Synthesis of 2′-Deoxy-β-D-Ribonucleosedes viaTransglycosylation of 6-Oxopurine Ribonucleosides. Nucleosides and Nucleotides 17: 1547-1556.

Boryski J (2008) Reactions of Transglycosylation in the Nucleoside Chemistry. Curr Org Chem 12: 309-325.

Carangio A, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J (2001) Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Pd-catalysed synthesis of 5-aryl derivatives and their biological evaluation. Antiviral Chem Chemother 12: 187-197.

Catuogno S, Esposito CL, Quintavalle C, Condorelli G, de Franciscis V, Cerchia L (2012) Nucleic acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 2012: 735135.

Chen BJ, Wu YL, Tanaka Y, Zhang W (2014) Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci 10: 1084-96.

Christman JK (2001) 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21: 5483-5495.

Diez-Torrubia A, Balzarini J, Andrei G, Snoeck R, De Meester I, Camarasa MJ, Velazquez S (2011) Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues. J Med Chem 54: 1927-42.

Felczak K, Drabikowska AK, Vilpo JA, Kulikowski T, Shugar D (1996) 6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity. J Med Chem 39: 1720-1728.

Fogt J, Januszczyk P, Framski G, Onishi T, Izawa K, De Clercq E, Neyts J, Boryski J (2008) Synthesis and antiviral activity of novel derivatives of 2'-beta-C-methylcytidine. Nucleic Acids Sym Ser 52: 605-6.

Framski G, Gdaniec Z, Gdaniec M, Boryski J (2006) A reinvestigated mechanism of ribosylation of adenine under silylating conditions. Tetrahedron 62: 10123-10129.

Gallego O (2015) Nonsurgical treatment of recurrent glioblastoma. Curr Oncol 22: e273-81.

Gomez G, Sitkovsky MV (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102: 4472-8.

Issa JP, Kantarjian HM, Kirkpatrick P (2005) Azacitidine. Nature Rev Drug Discov 4: 275-6.

Jahnz-Wechmann Z, Framski G, Januszczyk P, Boryski J (2015) Bioactive fused heterocycles: Nucleoside analogs with an additional ring. Eur J Med Chem 96: 388-396.

Januszczyk P, Fogt J, Boryski J, Izawa K, Onishi T, Neyts J, De Clercq E (2009) Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides. Nucleosides Nucleotides Nucleic Acids 28: 713-23.

Khaled A, Ivannikova T, Auge C (2004) Synthesis of unnatural sugar nucleotides and their evaluation as donor substrates in glycosyltransferase-catalyzed reactions. Carbohydr Res 339: 2641-9.

Koh YH, Shim JH, Girardet JL, Hong Z (2007) Design and evaluation of a potential mutagen for Hepatitis C virus. Bioorg Med Chem Lett 17: 5261-4.

Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L, Brem H (2007) Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 83: 61-70.

McGuigan C, Brancale A, Barucki H, Srinivasan S, Jones G, Pathirana R, Carangio A, Blewett S, Luoni G, Bidet O, Jukes A, Jarvis C, Andrei G, Snoeck R, De Clercq E, Balzarini J (2001) Furano pyrimidines as novel potent and selective anti-VZV agents. Antiviral Chem Chemother 12: 77-89.

McGuigan C, Hinsinger K, Farleigh L, Pathirana RN, Bugert JJ (2013) Novel antiviral activity of l-dideoxy bicyclic nucleoside analogues versus vaccinia and measles viruses in vitro. J Med Chem 56: 1311-22.

Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA (2003) A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Therap 100: 31-48.

Montgomery JA, Hewson K (1968) Analogs of 6-Methyl-9-β-ribofuranosylpurine. J Am Chem Soc 11: 48-52.

Neidle S, Thurston DE (2005) Chemical approaches to the discovery and development of cancer therapies. Nat Rev Cancer 5: 285-96.

Piwecka M, Rolle K, Wyszko E, Zukiel R, Nowak S, Barciszewska MZ, Barciszewski J (2011) Nucleic Acid-based Technologies in Therapy of Malignant Gliomas. Curr Pharmacet Biotech 12: 1805-1822.

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM (2011) Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 17: 1603-15.

Radi M, Schenone S, Botta M (2009) Recent highlights in the synthesis of highly functionalized pyrimidines. Org Biomol Chem 7: 2841-7.

Rolle K, Nowak S, Wyszko E, Nowak M, Zukiel R, Piestrzeniewicz R, Gawronska I, Barciszewska MZ, Barciszewski J (2010) Promising human brain tumors therapy with interference RNA intervention (iRNAi). Cancer Biol Therapy 9: 396-406.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352: 987-996.

Szymanska-Michalak A, Wawrzyniak D, Framski G, Kujda M, Zgola P, Stawinski J, Barciszewski J, Boryski J, Kraszewski A (2016) New 3'-O-aromatic acyl-5-fluoro-2'-deoxyuridine derivatives as potential anticancer agents. Eur J Med Chem 115: 41-52.

Tolstikov GA, Mustafin AG, Gataullin RR, Spirikhin LV, Suitanova VS, Abdrakhmanov LB (1993) New type of interaction of 5-iodopyrimidine nucleosides with alkynes. Russ Chem Bull 42: 563-598.

Vorbrüggen H, Bennua B (1978) New Simplified Nucleoside Synthesis. Tetrahedron Lett: 1339-1342.

Walker RT, De Clerq E, Eckstein F (ed.), Nucleoside Analogues: Chemistry, Biology, and Medical Applications, vol. Plenum Press, New York, New York, (1979).

Walton E, Jenkins SR, Nutt RF, Holly FW (1969) Branched-Chain Sugar Nucleosides. V. Synthesis and Antiviral Properties of Several Branched-Chain Sugar Nucleosides. J Med Chem 12: 306-309.

Wu R, Smidansky ED, Oh HS, Takhampunya R, Padmanabhan R, Cameron CE, Peterson BR (2010) Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. J Med Chem 53: 7958-66.

Xavier CP, Lima CF, Rohde M, Pereira-Wilson C (2011) Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol 68: 1449-57.

Xu LW, Chow KK, Lim M, Li G (2014) Current vaccine trials in glioblastoma: a review. J Immunol Res 2014: 796856.

Yang M-Y, Zetler PM, Prins RP, Khan-Farooqi H, Liau LM (2006) Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications. Expert Rev Neurotherapeutics 6: 1481-1494.

Zhang X, Zhang W, Cao WD, Cheng G, Zhang YQ (2012) Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review). Exp Ther Med 3: 9-14.